Drug intelligence / Profile preview

sodium sulfacetamide

Development stage
Unknown
Lead developer
Biocomp Pharma
Modality
Small Molecules
Administration
Topical, Ophthalmic
01

Overview

Sodium sulfacetamide is a sulfonamide antibiotic small molecule marketed by BioComp Pharma as a generic topical treatment for various dermatological conditions. It functions as a bacteriostatic agent by competitively inhibiting the bacterial enzyme dihydropteroate synthase (DHPS). This action prevents the incorporation of para-aminobenzoic acid (PABA) into dihydropteroic acid, thereby disrupting the synthesis of bacterial folic acid, which is essential for nucleic acid production. BioComp Pharma provides sodium sulfacetamide in several topical dosage forms, including cleansers, lotions, and washes, typically at a 10% concentration. These products are primarily indicated for the treatment of acne vulgaris, acne rosacea, and seborrheic dermatitis. While sodium sulfacetamide is also utilized in ophthalmic formulations for bacterial eye infections, BioComp's portfolio is centered on dermatologic applications.

Brand names
OVACE Plus Lotion
Other names
sulfacetamide sodiumN-Sulfanilylacetamide monosodium salt
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sodium sulfacetamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium sulfacetamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call